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Summary 
Background: Atherosclerosis is a chronic inflammatory dis-
ease which starts early in life and depends on many factors,
an important one being dyslipoproteinemia. According to
several studies, atherosclerotic plaques or their precursors
could be seen in children younger than 10 years. During
later life, interaction with a sedentary way of life, as well as
unhealthy nutrition, smoking, alcohol consumption, obesi-
ty and family history of cardiovascular disease cause the
burden of atherosclerotic disease. 
Methods: Study included 624 children (316 boys, 308
girls), aged from 7–13 years. We analysed socio-demo-
graphic data (BMI, blood pressure, cardiovascular family
history, smoking status), as well as lipid status with lipopro-
tein little a–Lp(a), and apolipoproteins: Apo AI, Apo B-100
for all children. This enabled us to calculate new athero-
genic indices Tg/HDL-c, lipid tetrad index (LTI) and lipid
pentad index (LPI). Cardiovascular risk for later life was esti-
mated by using modified Risk Score for Young Individuals
(RS), which divided the subjects according to the score
level: low, medium and higher risk.
Results: The older children (13 y) had better lipid status than
the younger children, i.e. significantly lower total cholesterol,
LDL-C, triglycerides and non-HDL-C concentration and sig-
nificantly higher HDL-C concentration than the younger chil-
dren and this was in accordance with the RS  level. Children
with a positive family history of CV disease had significantly
higher Lp(a) concentration and blood pressure. LPI was sig-
nificantly higher in children with a higher RS.
Conclusions: The results of our work could be used for car-
diovascular risk assessment in apparently healthy children
Kratak sadr`aj
Uvod: Ateroskleroza je hroni~na inflamatorna bolest koja po -
~inje rano u detinjstvu i zavisi od mnogo faktora; jedan od naj -
va`nijih je dislipoproteinemija. Razvoj aterosklerotskog plaka
po~inje pre desete godine `ivota. Interakcija sa sedentarnim
na~inom `ivota, nezdravom ishranom, pu {e njem, uno {e njem
alkohola, gojazno{}u i pozitivnom porodi~nom anam nezom
za kardiovaskularne bolesti uzrokuje razvoj atero sklerotske
bolesti u kasnijem dobu. Cilj ove stu dije je bio da se kod zdra -
ve dece izmere i procene pomenuti faktori rizika i kvantifikuje
rizik za razvoj ateroskleroze kasnije u `ivotu.
Metode: U studiju je uklju~eno 624 deteta (316 de~aka i
308 devoj~ica), uzrasta 7–13 godina. Analizirali smo in deks
te lesne mase – ITM, krvni pritisak, porodi~nu anamnezu,
status pu{enja, osnovni lipidni status sa dodatnim pa ra -
metrima: koncentracija lipoproteina a–Lp(a) i apolipopro-
teina: Apo AI, Apo B-100. Ra~unali smo nove aterogene
indekse: odnos koncentracija Tg i HDL-c, lipid tetrad (LTI) i
lipid pen tad indeks (LPI). Rizik za razvoj kardiovaskularnih
bo lesti u kasnijem `ivotu je procenjivan upotrebom Skora ri -
zi ka za mlade osobe (SR) na osnovu koga su ispitanici pode -
ljeni na one sa niskim, srednjim i vi{im rizikom.
Rezultati: Starija deca (13 g.) imaju bolji lipidni status od
mla|e dece, tj. ni`e koncentracije LDL-h, triglicerida i non-
HDL-h i vi{e koncentracije HDL-h, {to je bilo u skladu sa
nivoom SR. Deca sa pozitivnom porodi~nom anamnezom
imala su vi{e koncentracije Lp(a) i vi{i krvni pritisak. LPI je
bio zna~ajno vi{i kod dece sa vi{im SR. 
Zaklju~ak: Rezultati ove studije bi se mogli koristiti za pro-
cenu kardiovaskularnog rizika kod zdrave dece, da bi se
spre~io nastanak nekih od faktora rizika.
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Introduction
Atherosclerosis is a chronic inflammatory dis-
ease which starts early in life (1) and depends on
many factors; the most important one is dyslipopro-
teinemia i.e. lipid metabolism disturbance. According
to several studies, atherosclerotic plaques or their pre-
cursors could be seen in children younger than 10
years (2–5). During later life, interaction with seden-
tary lifestyle, coupled with unhealthy nutrition, smok-
ing, alcohol consumption, obesity and family history
of cardiovascular disease, causes the  burden of ath-
erosclerotic disease (2). Atherosclerosis is a prerequi-
site for different diseases development: acute myocar-
dial infarction, stroke, peripheral vascular disease and
many others. All of the abovementioned diseases are
characterized with high mortality rate, and increased
rate of patients’ disability, promoting atherosclerosis
as an important economic and social problem of the
modern societies, complex but preventable to a cer-
tain extent (3–5). 
Increased values of total cholesterol (T-C), triglyc -
 erides (TG), LDL-cholesterol (LDL-C), non-HDL-cho-
lesterol (non-HDL-C), and decreased HDL-C values
are all together important risk factors for atheroscle-
rotic changes in arteries in children (2). Moreover,
increased Apo B and Lp(a) and decreased Apo AI also
contribute to atherosclerosis risk (2). Lipid status
parameters, as well as Apo AI and Apo B are dietary
intervention modifiable parameters, and Lp(a) is an
independent risk factor which is genetically deter-
mined and nonmodifiable during life (6, 7). 
Obesity is also an independent risk factor for the
development of dyslipidemia, hypertension, and thus
cardiovascular disease in later life (8–10). According
to the data of the Insti tute of Public Health of Serbia
(11), people from Vojvodina (northern part of Serbia)
have the highest acute coronary syndrome mortality
rates per 100.000 subjects.
The aim of the present study was to explore car-
diovascular risk in apparently healthy children regard-
ing their general lipid status, Lp(a), apolipoproteins AI
and B-100 concentration, obesity and cardiovascular
related family history. 
Materials and Methods
This study included 624 elementary school chil-
dren (316 boys, 308 girls), divided in three groups
according to their age: 7 years (190 subjects), 10
years (212 subjects) and 13 years (222 subjects). The
study group was selected in South Banat (Vojvo dina,
Republic of Serbia) during regular medical check-up.
All the children and parents read and signed their in -
formed consent and all procedures were planned
according to the ethical guidelines of Helsinki De -
claration. The institutional ethical and review commit-
tee of the University of Belgrade Faculty of Phar macy
approved our study protocol. Data about family his -
tory regarding acute myocardial infarction and/or
stroke were collected from parents by the interviewer
during the same medical appointment. 
Venous blood was drawn from the antecubital
vein into evacuated, serum separator tubes, after 12
hours of overnight fasting. T-C and TG were assayed
immediately by routine enzymatic methods using an
Artax analyzer (Menarini, Florence, Italy) and Mena rini
reagents (Florence, Italy). HDL-C was isolated by
using the precipitating method with phosphotungstic
acid in the presence of Mg2+ ions. LDL-C concentra-
tion was calculated using the Friedewald formula (12). 
Serum aliquots were preserved at –80 °C until
analysis of apolipoproteins concentration (Apo AI and
Apo B-100), and lipoprotein little a – Lp(a). Apo AI,
Apo B and Lp (a) were assayed by routine immuno-
turbidimetric methods using the nephelometric analy -
ser BN proSpec and spectrophotometric analy ser Rxl
Max. The instruments were purchased from the same
manufacturer, DADA Behring (Margburg, Germany)
with DADA Behring reagents (Margburg, Germany). 
Non-HDL concentration is calculated as the dif-
ference between T-C and HDL-C, and atherogenic
index as the ratio between TG and HDL-C concentra-
tions. New atherogenic indices which involved se veral
lipid parameters were calculated as lipid tetrad index
(LTI) and lipid pentad index (LPI). LTI was calculated
using the formula [Tc×Tg×Lp(a)] /HDL-c, and LPI
was calculated using the formula: [Tc×Tg×Lp(a)×
apoB]/apoA-I (13).
Body mass was measured using a portable elec-
tronic scale (Tanita, Amsterdam, Netherlands) to the
nearest 0.1 kg. Height was measured to the nearest
0.1 cm using a portable wall-mounted stadiometer.
Waist (just above the iliac crest) and hip (the widest
part of the hips at the middle of the pelvis) circumfer-
ences were measured to the nearest 0.1 cm. Body
mass index was calculated as body weight (kg) divid-
ed by height squared (m). Overweight was defined as
a BMI ≥ 85th – < 95th percentile and obesity was
defined as a BMI ≥ 95th percentile for children of the
to provide preventive measures which could control the
change able risk factors.
Keywords: children, obesity, lipids, family history of
CVD, risk score
Klju~ne re~i: deca, gojaznost, lipidi, pozitivna porodi~na
anamneza kardiovaskularnih bolesti, skor rizika
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same age and sex. Blood pressure was measured by
a mercury sphygmomanometer (Quicksilver-sphy g mo -
 ma no meter Riester, Jungingen, Germany). 
Limits for prehypertension and hypertension sta-
tus are defined according to the Expert Panel on
Integrated Guidelines for Cardiovascular Health and
Risk Reduction in Children and Adolescents (13).
The risk for CVD was estimated using LTI and LPI
(14) and modified Risk Score for identifying young indi-
viduals with a high probability of having advanced ath-
erosclerotic lesions, reported by McMa han et al. (15).
According to risk score values, we have additionally
divided the children into Low risk group (score lower or
equal to 4 points), Medium risk group (5–8 points) and
Higher risk group (above 8 points). 
Statistical Methods
Parameters with a normal, Gaussian type of dis-
tribution are presented as means and standard devia-
tions, but triglycerides, Lp(a), LTI, LPI deviated from
normal distribution and are presented as geometrical
mean and 95% confidence interval. For inter-group
comparison, we have used ANOVA or Kruskal-Wallis
test, with the distinct post hoc test where appropriate
and chi-square test for frequency data comparison.
ROC analysis was used to test the discriminatory
capability of the measured and/or calculated param-
eters regarding low and higher risk status towards
cardiovascular disease. 
Results
We have compared basic lipid status parameters
and parameters connected with lipid metabolism in
children divided in groups according to their age, by
using ANOVA and post hoc Tukey test for data with
Gaussian distribution. Data which deviated from
Gaus sian distribution were compared with nonparam -
etric methods (Kruskal-Wallis ANOVA followed by
Mann-Whitney U test). The results are presented in
Table I. 
The older children (13 y.) had better lipid status
than younger children, i.e. significantly lower total
cholesterol, LDL-C, triglycerides and non-HDL-C con-
centrations and significantly higher HDL-C concentra-
tions than the younger children. Moreover, 13 y. old
children had lower Lp(a), and higher Apo AI than the
two younger groups. The oldest children also had the
a, aaaP<0.05, 0.001, compared to 7 y. group; b,bbbP<0.05, 0.001 compared to 10 y. group
# – parameters with non-Gaussian distribution presented as 50th percentile (25th – 75th percentile); compared by nonpara-
metric Kruskal-Wallis ANOVA and subsequent Mann-Whitney U test
Table I Basic anthropometric, lipid status, and inflammation parameters in healthy children according to the age subgroups.
Parameter Age subgroups
7 y. (n=190) 10 y. (n=212) 13 y. (N=222) P
Sex, boy/girl, n (%) 99/91 (52/48) 101/111 (48/52) 116/106 (52/48) χ2=1.15, P=0.560
BMI, kg/m2 19.97±3.10 21.77±3.89aaa 19.84±3.51bbb <0.001
Systolic BP, mm Hg 110.53±10.38 114.03±13.77a 111.02±13.46 <0.01
Diastolic BP, mm Hg 72.24±10.50 75.78±12.00a 72.64±11.79b <0.003
Positive family history 
for CVD, n (%) 10 (5.3%) 17 (8%) 25 (11%) χ
2=4.86, P=0.088
Glucose, mmol/L 4.62±0.53 4.68±0.47 4.70±0.53 0,158
TC, mmol/L 4.56±0.79 4.58±0.71 4.12±0.66aaa,bbb <0.001
TG, mmol/L# 1.19 (1.12–1.27) 0.94 (0.89–0.99)aaa 0.87 (0.82–0.91)aaa <0.001
LDL-C, mmol/L 2.44±0.93 2.69±0.70aa 2.14±0.82aa,bbb <0.001
HDL-C, mmol/L 1.51±0.43 1.43±0.34 1.58±0.61 bb <0.003
Non-HDL-C, mmol/L 3.04±0.88 3.16±0.74 2.53±0.75aaa,bbb <0.001
Apo AI, g/L 1.34±0.38 1.37±0.29 1.45±0.40aa, b 0.003
Apo B-100, g/L 0.80±0.32 0.91±0.28aaa 0.80±0.31bbb <0.001
Lp(a), mg/L# 222 (204–242) 171 (157–187)aaa 168 (143–197)aaa <0.001
TG/HDL-C# 0.838 (0.555–1.203) 0.639 (0.480–0.876)aaa 0.538 (0.409–0.868)aaa,bb <0.001
LTI# 722 (450–1695) 474 (271–757)aaa 280 (199–716)aaa <0.001
LPI# 695 (373–1308) 417 (244–790)aaa 235 (126–600)aaa,bbb <0.001
Fibrinogen, g/L 3.1 (2.6–3.6) 3.0 (2.6–3.5) 3.0 (2.7–3.3) 0.220
lowest LTI and LPI risk scores values. The number of
children with positive family history for coronary heart
disease increased with age, but the difference was not
statistically significant. Afterward, we divided the chil-
dren according to their family history for CV disease
status and compared the other measured parameters.
Our results showed that children with a positive fami-
ly history of CV disease had significantly higher Lp(a)
concentration, and blood pressure (Figure 1).
In order to estimate possible risk for cardiovascu-
lar disease development in apparently healthy chil-
dren, we used the Risk Score Calculator proposed by
McMahan et al. (15). This calculator uses non-HDL-C,
HDL-C, smoking status, hypertension, hypergly cemia,
and sex parameters for the risk score calculation. 
Figure 2 shows risk score values in the age sub-
groups. Younger age groups of children have signifi-
cantly higher risk score values compared to 13 y. old
children (data are presented in Figure 2 as box plots
of median values and interquartile range). 
Then, we divided the group of healthy children
into three subgroups stratified by the calculated risk
score level as Low, Medium and Higher risk groups.
The re sults of this part of analysis are shown in Table
II. Unexpectedly, the youngest children had the high-
est level of risk for CVD development in later life when
compared to the older children subgroups. These
children had significantly higher BMI, and worse lipid
status than the children with lower risk and also high-
er blood pressure. The number of positive family his-
tory for CVD children did not differ among the risk
level subgroups. Regarding LTI and LPI values, chil-
dren with higher risk score for CVD value had the lat-
ter index significantly higher compared to the same
parameter in both lower risk groups (Figure 3).
We also wanted to test the lipid status, inflamma-
tion and BMI parameters’ capability to discriminate bet -
ween Low Risk and Higher Risk status, so we perfor -
med the receiver operating characteristics curve (ROC)
analysis. The parameters analysed were those which
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Figure 1 Differences in Lp(a) concentration and blood pressure values in two categories related with presence of family his-
tory of cardiovascular disease in apparently healthy children.
*P<0.05 vs. Negative family history children (Lp(a) compared by Mann-Whitney U test; blood pressure compared with
Student's t test)
Figure 2 Risk score value in different age groups.
aaa, bbbP< 0.001 vs. 7 y. and 13 y. respectively according
to Kruskal-Wallis and then Mann-Whitney U test
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Figure 3 Lipid tetrad (LTI) and lipid pentad index (LPI) according to risk score values subgroups.
(aaP<0.01, aaaP<0.001 vs. Low risk group, bP<0.05, bbP<0.01 vs. Medium risk group)
Table II Biochemical parameters in healthy children (7–13 y.) according to risk score level subgroups.
Risk score value P
Parameter







Age 10.4±2.46 9.4±2.06aa 8.5±1.94aaa <0.001
BMI, kg/m2 20.3±3.39 21.1±4.43 22.6±4.19aa <0.01
TC, mmol/L 4.25±0.661 4.90±0.683aaa 5.78±0.350aaa, bbb <0.001
TG, mmol/L 1.06±0,503 1.08±0.461 1.52±0.881aaa, bbb <0.001
LDL-C, mmol/L 2.21±0.739 3.15±0.624aaa 3.91±0.497aaa, bbb <0.001
TG/HDL# 0.615 (0.445–0.909) 0.811(0.580–1.153) 1.194 (0.714–1.536)a 0.011
Lp(a), mg/L# 179 (100–280) 170 (100–270) 240 (146–382) ns
Apo AI, g/L 1.40±0.356 1.34±0.362 1.44±0.363 ns
Apo B-100, g/L 0.829±0.289 0.860±0.365 0.889±0.400 ns
Fibrinogen, g/L 3.04±0.551 3.00±0.589 3.02±0.550 ns
Systolic BP, mm Hg 110±12 117±12aaa 123±12aaa <0.001
Diastolic BP, mm Hg 72±11 78±12aaa 82±16aaa <0.001
Risk score value (points)# 2.0 (–1.0–3.0) 6.0 (5.0–6.0)aaa 8.0 (8.0–9.0)aaa, bbb <0.001
Positive family history for CVD
n (%) 41 (8%)           8 (9%) 3 (12%) 
c2=0.4,
P=0.818                
a,aa,aaaP<0.05, 0.01, 0.001, compared to Low Risk group; bbbP< 0.001 compared to Medium Risk group with ANOVA and
Tukey test 
ns-non-significant; # – parameters with non-Gaussian distribution presented as 50th (25th – 75th percentile); compared by non-
parametric Kruskal-Wallis ANOVA and subsequent Mann-Whitney U test
were not used for Risk Score calculation. The results of
this analysis are shown in Table III and Figure 4.
Total cholesterol and LDL-C had the best dis-
criminatory potential, which was not unexpected be -
cause non-HDL cholesterol was used for the Risk
Score calculation. LPI and BMI had significantly lower
AUCs and thus lower discriminating power, but still
the AUCs were significantly higher than 0.5. 
Discussion 
Many studies, among them YUSAD study (16)
and Bogalusa study (17, 18) indicate a close relation-
ship between lipid and nonlipid atherogenic risk fac-
tors in early childhood and atherosclerosis develop-
ment in later life. Identification of the risk factors and
their li mitation lead to significant decrease of the pos-
sibility of cardiovascular disease development (19).
BMI values among the age groups increased
with age when we compared the 7 y. and 10 y. sub-
groups (19.97±3.10 kg/m2 vs. 21.77±3.89 kg/m2,
P<0.001) and decreases in 13 y subgroup (19.84±
3.51, P<0.001 compared to 10 y. subgroup). This
BMI changing with the children’s development is the
same as in Ninic et al. (20), who assessed 7–15 y. old
children from Vojvodina. Systolic and diastolic pres-
sure values are comparable with Lurbe et al. data (21)
for healthy children and adolescents aged 1–17 y.
There was no difference in blood pressure values
among different age groups (Table I). 
Triglycerides, non-HDL-C and Tg/HDL-C ratio
(Table I) are higher than Ninic et al. (20) reported.
Older children in our current study had better lipid
status than the younger ones; significantly lower total
cholesterol values, LDL-C, triglycerides, non-HDL-C
and Lp(a), and also significantly higher HDL-C and
Apo-AI. Lipid parameter values in children from this
study are within the recommended boundaries given
by Serbian National Guide for Good Clinical Practice
(22–24). According to this recommendation for lipid
disorder diagnosis and treatment, for children, bor-
derline LDL-C concentrations are considered those
higher than 2.85 mmol/L and high are above 3.36
mmol/L; borderline high total cholesterol value is
above 4.40 mmol/L and T-C values higher than 5.17
mmol/L are considered high. Schulpis et al. (25, 26)
have investigated lipid parameters’ distribution in
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Table III The results of ROC analysis for discriminating two
risk levels i.e. risk score below 4 and risk score ≥ 8.
Variable AreaC 95% ConfidenceInterval Std. Error
TC 0.969*** 0.949–0.989 0.010
LDL-C 0.968*** 0.941–0.995 0.014
Tg 0.663** 0.551–0.776 0.057
Lp(a) 0.601 0.495–0.707 0.054
Apo AI 0.566 0.452–0.679 0.058
Apo B 0.469 0.352–0.587 0.060
LTI 0.562 0.447–0.677 0.059
LPI 0.680** 0.584–0.776 0.049
BMI 0.662** 0.544–0.780 0.060
Fibrinogen 0.499 0.378–0.620 0.062
**, ***P<0.01 and 0.001 respectively for AUC values 
compared to 0.5
Figure 4 ROC curves for lipids, lipoproteins, apolipoproteins, BMI and fibrinogen and their ratios as markers of risk of cardio-
vascular disease development in later life. Panel A) HDL-c, TC, LDL-C, TG, Lp(a);  panel B) BMI, fibrinogen; panel C) Apo AI,
Apo B-100, LTI and LPI.
Greek children and their results showed slightly high-
er levels of serum HDL-C and lower levels of TG, LDL-
C and Lp(a) than in our children of similar age. Better
lipid status of the Greek schoolchildren could be
explained with the genetic factors and by the nutri-
tional habits of the Greek population, regarding con-
sumption of olive oil and other components of the
Mediterranean diet. This finding compared to our
results could imply that healthier nutritional habits
could be protective concerning the risk for CVD de -
velopment in later life.
LTI and LPI indices are calculated in order to
assess more precisely the cardiovascular risk coming
from a detailed lipid status. It is evident that older
children had lower LTI and LPI compared to younger
children (Table I). The LTI and LPI indices have
recently been described as a new form of assessment
of lipid profiles, which have been analysed in some
populations (27). A characteristic of these new
indices is the broad approach to atherogenic and
nonatherogenic lipid particles, resulting in a single
value. Based on the conventional lipid profile and the
emerging risk factors such as Lp(a), apolipoproteins
AI and B-100, the LTI and LPI appear as models in
global risk assessment, reflecting the multifactorial
nature of CVD. Bogalusa (17) and YUSAD (16) stud-
ies analyzed the relation between lipid status and age
of children. The YUSAD study (16) demonstrated that
over a 5 and 10-year period (10 y. children compared
to 15 y. and 20 y. children), BMI and waist circumfer-
ence values showed significant increase. Such an
observation is in correlation with the physiological
changes (growth) during this period. However, the
proportion of the waist circumference increase was
higher in girls between 10 and 15 years of age than
between 15 and 19–20 years of age, while there was
less discrepancy in the difference between the pro-
portions of the two 5-year age groups in boys’ popu-
lation. Moreover, the authors of the Bogalusa study
(17, 18) showed a connection between obesity and li -
pid status, and suggested a relation between high in -
sulin concentration and cardiovascular risk. Chil dren
from our study were all normoglycemic, so we suppo -
sed that their insulin concentrations were among refer-
ence values (28), and did not contribute to increased
CV risk.
BMI and lipid status values are comparable with
values reported by Costa et al. (29), who found a neg -
ative correlation between BMI and HDL-C values, and
a positive correlation between BMI and triglyceride
concentration in a group of children younger than 12
y. Dai et al. (30) and Jolliffe and Janssen (31) have
similar results and have commented about lipid status
dependence on age. The age and gender specific
threshold values reflect the natural fluctuation in
lipoprotein concentration that occurs with growth and
maturation. Difference in lipid status between 13 y
old children and the younger ones could be explained
by their puberty status and the intensive growth peri-
od of older children. Namely, the metabolism of
puberty period children is devoted to rapid growth
and protein synthesis (16, 21, 32). The decrease in
serum lipids levels during puberty is also related to an
increase in the plasma testosterone concentration in
boys or estradiol concentration in girls (32).
We included 624 children in total, among them
52 (8.3%) with a positive family history regarding car-
diovascular disease (presence of hypertension, acute
myocardial infarction or stroke in first or second line
relatives). As expected, the number of positive family
history cases increased with increasing age (5.3%, vs.
8.0% vs. 11%, with a marginally statistically signifi-
cant difference P=0.088), because in younger chil-
dren relatives are also younger and with smaller
chances of having some unwanted cardiovascular
related condition. Our results showed significantly
higher Lp(a) and blood pressure values in children
with positive family history compared to children with-
out family history of CVD (Figure 1). Still, Lp(a) values
in our group of children with CVD family history were
lower than in Italian children of similar age who also
had CVD family history (19), but higher compared
with healthy 14 y. old Swedish children from
Bergström’s study (22). It is well-known that Lp(a) is
an independent CV risk factor (6, 7) and in creased
values of this parameter could predict early cardiovas-
cular disturbance development, even if other riskfac-
tors are within a tolerable range (18). On the con-
trary, Guardamagna et al. (19) considered that the
mutual involvement of increased Lp(a) values with po -
sitive family history was directly connected with
increased risk for cardiovascular development. Similar
findings have been presented by others (29, 31),
regarding positive correlation between increased
Lp(a) values and LDL-c concentrations, as well as
Lp(a) and total cholesterol values and Apo B-100
(19), especially in children with positive family history.
According to our results, significantly higher Lp(a)
concentration and blood pressure values reflected
additional risk factor existence such as positive family
history of CVD. 
In order to assess the real cardiovascular risk
level, we implemented the scale for Cardiovascular
Risk Score (CRS) calculation from McMahan’s study
(15). That study correlated the cumulative effects of
modifiable risk factors (non-HDL-cholesterol, HDL-
cholesterol, smoking, hypertension, obesity and hy per -
 glycemia) and the level of atherosclerotic deposits on
coronary arteries. Scoring system given by McMa han
et al. (15) gave the ratio between RS level and proba-
bilities of having significant stenosis on coronary arter-
ies, where score 10 gives the probability of 10%, score
20 – 25% and score 30 – almost 60% for having sig-
nificant atherosclerotic lesions. In our current study,
apparently healthy children aged 7–13 y. had RS lev-
els from –1 to 11, which means that at the moment,
children had about 10% probability of ha v ing signifi-
cant atherosclerosis on coronary arteries. How ever, in
order to grade the risk level, we divided the children
according to tertile values for this group; i.e. Low CRS
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≤ 4 (N=506), Medium CRS 5–7 (N=92) and Higher
CRS ≥ 8 (N=26) (Table II). Along with better lipid sta-
tus, older children had significantly lower CRS values
than younger children (Figure 2). Nonetheless, chil-
dren with the highest CRS values had also significant-
ly higher values of total cholesterol, triglycerides, LDL-
c, Tg/HDL-c ratio, Lp(a) concentration and systolic
and diastolic blood pressure (Table II). These findings
are in accord with other studies (32–35) which
assessed risk factors in adolescents or young adults
and then measured carotid artery intima-media thick-
ness (IMT) in the same individuals, 12 to 22 years
later. In all of these studies, one or more of the risk fac-
tors were associated with the carotid IMT of individu-
als. The study of Bild et al. (36) found a similar asso-
ciation between coronary arteries calcification and risk
factors measured 10 years earlier. Oren et al. (37)
found strong associations between current risk factors
and carotid IMT in young adults. LTI and LPI values
are also higher in higher CRS values groups, and this
finding is in agree ment with Morais, McMahan and
Das’ work (14, 15, 27). These findings reinforce the
idea that the conventional lipid profile in many cases
may not offer an actual estimation of coronary risk.
When this profile is under reference limits, it does not
necessarily rule out the risk due to specific forms of
dyslipidemia. Conse quently, the introduction of labora-
tory tests related to an uncon ventional lipid profile
would be extremely desirable in search of the real
coronary risk estimate, as an addition to all the other
traditionally investigated risk factors. 
We wanted to estimate which of the measured
parameters could predict CRS value, so we imple-
mented a ROC analysis. The result of ROC analysis
showed that, besides total cholesterol and LDL-C
which are directly connected with non-HDL-C, as one
of the points for the CRS calculation, LPI and BMI had
good predictive potential (Table III, Figure 4). This
suggested that the values of the comprehensive pa -
rameter LPI, which included several lipid parameters,
and which is the most important Lp(a), could be a
reliable sign of growing cardiovascular risk. Our re -
sults are in agreement with Bogavac-Sta nojevic et al.
study (38). We have considered only lipid, anthropo-
metric and family history related risk, as some kind of
traditional cardiovascular risk factors. Karikas et al. (39)
proposed assessment of several other new, emer ging
risk factors in early age. Those parameters were homo -
cy steine and paraoxonase activity, as already estab-
lished cardiovascular risk factors in the adult popu -
lation. According to this, the additional work in
athero sclerosis related risk factors recognition in chil-
dren is certainly warranted in the future. 
We believe that the results of our current work
could be used by clinicians in order to arrange pre-
ventive measures to control changeable risk factors in
children.
Acknowledgements 
This work was financially supported by grants
from the Serbian Ministry of Education, Science and
Technological Development (Project number 175035).
The study funder had no role in study design, in the
collection, analysis, and interpretation of data; nor in
the writing of the report and the decision to submit
the manuscript for publication.
Conflict of interest statement
The authors stated that they have no conflicts of
interest regarding the publication of this article.
300 D`elajlija et al.: Children and cardiovascular risk
References
1. Mellies M, Glueck CJ. Lipids and the development of ath-
erosclerosis in schoolchildren. J Paediatr Gastroenterol
Nutr 1983; 2: 5298–03.
2. da Luz GM, Villela Barocini LA, Champoski AF, Carla A,
Biazon B. Household cardiovascular screening in adoles-
cents from high-risk families. Atherosclerosis 2013; 226
(1): 286–90.
3. Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular
disease in paediatric chronic dialysis patients. Kidney Int
2002; 62: 648–53.
4. Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszyñ -
ska J, Jobs K, at al. Survival and causes of death in chil-
dren on haemodialysis and continuous ambulatory peri-
toneal dialysis. Pediatr Nephrol 2001; 16: 996–01.
5. McDonald SP, Craig JC. Long-term survival of children
with end stage renal disease. N Engl J Med 2004; 350:
2654–62. 
6. Sandkamp M, Kunke H. Lipoprotein (a) is an independ-
ent risk factor for myocardial infarction in young age. Clin
Chem 1990; 36: 20–3.
7. Krempler F, Kostner G, Bolzano K, Sandhofer F. Lipo -
protein (a) is not a metabolic product of other lipopro-
teins constraining apolipoprotein B. Biochim Biophys
Acta 1979; 575: 63–70.
8. Must A, Strauss RS. Risk and consequences of childhood
and adolescent obesity. Int J Obes Relat Metab Disord.
1999; 23: 2–11. 
9. Kocova M, Sukarova-Angelovska E, Tanaskoska M, Pal -
cevska-Kocevska S, Krstevska M. Metabolic setup and
risks in obese children. J Med Biochem 2015; 34: 31–7.
10. Zdravkovi} V, Saji} S, Mitrovi} J, Stefanovi} I, Pa vi }evi}
P, Nikoli} D, Dimi} J, Lali} MN.The diagnosis of predi-
abetes in adolescents. J Med Biochem 2015; 34:
38–45.
J Med Biochem 2016; 35 (3) 301
11. Incidence and mortality of acute coronary syndrome in
Serbia, Institute of Public Health of Serbia »Dr Milan
Jovanovi} Batut« Belgrade 2013.
12. Friedewald WT, Levy RI. Fredericson DS estimation of the
concentration of low density lipoprotein cholesterol in
plasma, without use of the preparative ultracentrifuge.
Clin Chem 1972; 18: 499–507. 
13. Age specific recommendations for blood pressure (BP)
measurement and diagnosis of Hypertension 27–37. In:
Expert panel on integrated guidelines for cardiovascular
health and risk reduction in children and adolescents. US
De partment of Health and Human Servises, National
Heath, Lung and Blood Institute. 12-7486A October 2012.
14. Morais CAS, Oliviera SHV, Lima LM. Lipid tetrad index
(LTI) and lipid pentad index (LPI) in healthy subjects. Arg
Bras Cardiol 2013; 100: 322–7. 
15. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Mal -
com GT, Tracy RE, et al. Risk scores predict atheroscle-
rotic lesions in young people. Arch Intern Med 2005;
165: 883–90.
16. Simeunovi} S, Nedeljkovi} S, Milin~i} Z, Vukoti} M,
Nova kovi} I, Nikoli} D, et al. Anthropometric and lipid
parameters trends in school children: one decade of
YUSAD Study. Srp Arh Celok Lek 2011; 139: 465–9. 
17. Berenson GS, Srinivasan SR, Bao W, Newman WR, Tracy
RE, Wattigney WA. Association between multiple cardio-
vascular risk factors and atherosclerosis in children and
young adults: Bogalusa Heart Study. N Engl J Med 1998;
338: 1650–56.  
18. Freedman DS, Serdula MK, Srinivasan SR, Berenson GS.
Relation of circumferences and skinfold thicknesses to
lipid and insulin concentrations in children and adoles-
cents: the Bogalusa Hearth study. Am J Clin Nutr 1999;
69: 308–17. 
19. Guardamagna O, Abello F, Anfossi G, Piro M. Lipo pro tein
(a) and family history of cardiovascular disease in children
with family dyslipidemias. J Pediatr 2011; 159: 314–9.
20. Nini} A, Spasojevi}-Kalimanovska V, Kotur- Stevuljevi} J,
Bogavac-Stanojevi} N, Stefanovi} A, Jeli}-Ivanovi} Z, et
al. Associations between anthropometric parameters and
serum lipids in preadolescent and adolescent girls and
boys. Clin Lipidol 2015; 10: 2. 
21. Lurbe E, Cifkova R, Cruickshank K. Management of high
blood pressure in children and adolescents: recommen-
dations of the European Society of Hypertension. J Hy -
per tens 2009; 27: 1719–42. 
22. Karbasy K, Ariadne P, Gaglione S, Nieuwesteeg M, Adeli
K. Advances in Pediatric Reference Intervals for Bio -
chemical Markers: Establishment of the CALIPER
Database in Healthy Children and Adolescents. J Med
Biochem 2015; 34: 23–30.
23. National Cholesterol Education Program (NCEP): high-
lights of the report of the expert panel on blood choles-
terol levels in children and adolescents. Pediatrics 1992;
89: 495–501.
24. Mila{inovi} G. Lipids disorder in: National guide of good
clinical practice for lipid disorder diagnosis and treat-
ment. Agency for accreditation of health care institutions
in Serbia, Belgrade, Serbia 2012; 18, www.zdravlje.gov.
25. Schulpis KH, Karikas GA, Gavrili S, Georgala S. Evalua -
tion of serum lipoprotein (a) levels in Greek schoolchil -
dren. Acta Paediatr 2001; 90: 225–6.
26. Schulpis K, Karikas GA. Serum cholesterol and triglyc-
eride distribution in 7767 school-aged Greek children.
Pediatrics 1998; 101: 5.
27. Das B, Daga MK, Gupta SK. Lipid pentad index: a novel
bioindex for evaluation of lipid risk factors for atheroscle-
rosis in young adolescents and children of premature
coronary artery disease patients in India. Clin Biochem
2007; 40: 18–24.
28. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R,
Nathan DM. Impaired glucose tolerance, but not im -
paired fasting glucose, is associated with increased level
of coronary heart disease risk factors. Results from the
Baltimore Longitudinal Study on Aging. Diabetes 2004;
53: 2095–2100.
29. Costa GB, Horta N, Resende ZF. Body mass index has a
good correlation with proatherosclerotic profile in chil-
dren and adolescents. Arg Cardiol 2009; 93: 261–7. 
30. Dai S, Fulton JE, Harrist RB, Grunbaum JA, Steffen LM,
Labrthe DR. Blood lipids in children: age-related patterns
and association with body-fat incidences: Project heart-
beat! Am J Prev Med 2009 (1); 37: 56–64.
31. Jolliffe CJ, Jansen I. Distribution of lipoproteins by age and
gender in adolescents. Circulation 2006; 114: 1056–62. 
32. Sto`icky F, Slaby P, Volenikova L. Longitudinal study of se -
rum cholesterol, apolipoproteins and sex hormones dur-
ing puberty. Acta Paediatr Scand 1991; 80: 1139–44.
33. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid inti-
mal-medial thickness is related to cardiovascular risk fac-
tors measured from childhood through middle age: the
Muscatine Study. Circulation 2001; 104: 2815–19.
34. Li S, Chen W, Srinivasan SR. Childhood cardiovascular
risk factors and carotid vascular changes in adulthood:
the Bogalusa Heart Study. JAMMA 2003; 290: 2271–6.
35. Raitakari OT, Jounala M, Kahonen M. Cardiovascular risk
factors in childhood and carotid artery intima-media
thick ness in adulthood: the Cardiovascular in Young
Finns Study. JAMMA 2003; 290: 2277–83.
36. Bild DE, Folsom AR, Lowe LP. Prevalence and correlates
of coronary calcification in black and white young adults:
the coronary artery risk development in young adults
(CARDIA) Study. Arterioscler Thromb Vasc Biol 2001;
21: 852–7.
37. Oren A, Vos LE, Uiterwaal CS, Grobbee, DE, Bots ML.
Cardiovascular risk factors and increased carotid intima-
media thickness in healthy young adults: the atheroscle-
rosis risk in young adults (ARYA) study. Arch Intern Med
2003; 163: 1787–92. 
38. Bogavac-Stanojevic N, Jeli}-Ivanovi} Z, Spasojevi}-Kali -
manovska V, Spasi} S, Kalimanovska-O{tri} D. Lipid and
inflammatory markers for the prediction of coronary arte -
ry disease: A multi-marker approach. Clin Biochem 2007;
40: 1000–06.
39. Karikas GA, Kriebardis A, Samara I, Schulpis K, Papa chri -
st odoulou K, Fytou-Pallikari A. Serum homocysteine levels
and paraoxonase 1 activity in preschool aged children in
Greece. Clin Chem Lab Med 2006; 44 (5): 623–7.
Received: November 26, 2015
Accepted: December 24, 2015
